Explore relationships stated by the original sources. Each number opens its exact collection—not a count of extra papers or proven treatments.
FDA application actionOctober 14, 2025
liraglutide
Approved submission · SUPPL 26
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
liraglutide
Approved submission · SUPPL 46
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
liraglutide
Approved submission · SUPPL 22
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
semaglutide
Approved submission · SUPPL 35
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
semaglutide
Approved submission · SUPPL 37
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
semaglutide
Approved submission · SUPPL 26
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Prevalence of Sarcopenia and Its Association with Malnutrition in Hospitalized Elderly Patients
Organization linked by OpenAIRE · Dokuz Eylül University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Prevalence of Sarcopenia and Its Association with Malnutrition in Hospitalized Elderly Patients
Organization linked by OpenAIRE · Dokuz Eylül Üniversitesi Hastanesi
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Prevalence of Sarcopenia and Its Association with Malnutrition in Hospitalized Elderly Patients
Organization linked by OpenAIRE · Celal Bayar University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Prevalence of Sarcopenia and Its Association with Malnutrition in Hospitalized Elderly Patients
Organization linked by OpenAIRE · Istanbul Medeniyet University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Bacterial exposure shapes the trajectory of immune ageing
Organization linked by OpenAIRE · Technion – Israel Institute of Technology
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Bacterial exposure shapes the trajectory of immune ageing
Organization linked by OpenAIRE · Comenius University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Shedding light on sleep: Investigating the impact of light on sleep and neurobehavioral outcomes in older adults with sleep disturbance
Organization linked by OpenAIRE · Macquarie University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Aging with HIV: multimorbidity and polypharmacy burden
Organization linked by OpenAIRE · Istanbul Medipol University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming
Organization linked by OpenAIRE · State Key Laboratory of Natural Medicine
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming
Organization linked by OpenAIRE · China Pharmaceutical University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming
Organization linked by OpenAIRE · Nanjing Drum Tower Hospital
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming
Organization linked by OpenAIRE · Nanjing University of Chinese Medicine
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Organization linked by OpenAIRE · SIB Swiss Institute of Bioinformatics
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Organization linked by OpenAIRE · University of Lausanne
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Organization linked by OpenAIRE · École Polytechnique Fédérale de Lausanne EPFL
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Organization linked by OpenAIRE · University of Amsterdam
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Organization linked by OpenAIRE · Universidad Católica San Antonio de Murcia
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 13, 2025
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Organization linked by OpenAIRE · Amsterdam Cardiovascular Sciences
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →